BR112022004976A2 - Composições com base em cepas bacterianas e extratos de baga e uso do mesmo como anti-inflamatórios - Google Patents
Composições com base em cepas bacterianas e extratos de baga e uso do mesmo como anti-inflamatóriosInfo
- Publication number
- BR112022004976A2 BR112022004976A2 BR112022004976A BR112022004976A BR112022004976A2 BR 112022004976 A2 BR112022004976 A2 BR 112022004976A2 BR 112022004976 A BR112022004976 A BR 112022004976A BR 112022004976 A BR112022004976 A BR 112022004976A BR 112022004976 A2 BR112022004976 A2 BR 112022004976A2
- Authority
- BR
- Brazil
- Prior art keywords
- bacterial strains
- inflammatories
- compositions based
- compositions
- berry extracts
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 230000001580 bacterial effect Effects 0.000 title abstract 3
- 235000021028 berry Nutrition 0.000 title abstract 3
- 229940121363 anti-inflammatory agent Drugs 0.000 title abstract 2
- 239000002260 anti-inflammatory agent Substances 0.000 title abstract 2
- 239000000284 extract Substances 0.000 title abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 abstract 1
- 241000186016 Bifidobacterium bifidum Species 0.000 abstract 1
- 241000186605 Lactobacillus paracasei Species 0.000 abstract 1
- 241000218588 Lactobacillus rhamnosus Species 0.000 abstract 1
- 229940002008 bifidobacterium bifidum Drugs 0.000 abstract 1
- 230000002519 immonomodulatory effect Effects 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/40—Cornaceae (Dogwood family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/736—Prunus, e.g. plum, cherry, peach, apricot or almond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/515—Animalis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
- A23V2400/517—Bifidum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
a presente invenção refere-se a composições b que compreendem uma mistura que compreende ou, alternativamente, que consiste em: pelo menos uma cepa bacteriana selecionada a partir de um grupo que compreende ou, alternativamente, que consiste em cepas bacterianas pertencentes às espécies lactobacillus paracasei, lactobacillus rhamno-sus, bifidobacterium bifidum e bifidobacterium animalis subsp. lactis e, de preferência, pelo menos um extrato de pelo menos uma espécie de bagas que compreende uma fração polifenólica das ditas bagas. além disso, a presente invenção refere-se às ditas composições b para uso como agentes imunomoduladores e anti-inflamatórios.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT102019000016850A IT201900016850A1 (it) | 2019-09-20 | 2019-09-20 | Composizioni a base di ceppi batterici e estratti di bacche e loro uso come antinfiammatori |
PCT/IB2020/058777 WO2021053641A2 (en) | 2019-09-20 | 2020-09-21 | Compositions based on bacterial strains and berry extracts and their use as anti-inflammatories |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112022004976A2 true BR112022004976A2 (pt) | 2022-06-21 |
Family
ID=69375790
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112022004976A BR112022004976A2 (pt) | 2019-09-20 | 2020-09-21 | Composições com base em cepas bacterianas e extratos de baga e uso do mesmo como anti-inflamatórios |
Country Status (11)
Country | Link |
---|---|
US (1) | US20220370520A1 (pt) |
EP (1) | EP4031156A2 (pt) |
JP (1) | JP2023507048A (pt) |
CN (1) | CN114728033A (pt) |
AU (1) | AU2020347962A1 (pt) |
BR (1) | BR112022004976A2 (pt) |
CA (1) | CA3154980A1 (pt) |
IL (1) | IL291448A (pt) |
IT (1) | IT201900016850A1 (pt) |
MX (1) | MX2022003375A (pt) |
WO (1) | WO2021053641A2 (pt) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITMI20131467A1 (it) | 2013-09-06 | 2015-03-07 | Sofar Spa | Uso di una composizione comprendente microrganismi per aumentare la produzione intestinale di acido butirrico, di acido folico o di niacina e/o per diminuire la produzione intestinale di acido succinico |
MA39710A (fr) | 2014-04-23 | 2015-10-29 | Sofar Spa | Composition topique destinée à être utilisée dans le traitement d'une maladie inflammatoire de l'intestin |
MA45288A (fr) | 2016-06-08 | 2019-04-17 | Sofar Spa | Nouvelle utilisation médicale de probiotiques |
IT201600122724A1 (it) | 2016-12-02 | 2018-06-02 | Sofar Spa | Exopolysaccharides and uses thereof |
IT201600127498A1 (it) | 2016-12-16 | 2018-06-16 | Sofar Spa | Probiotici per uso nella diverticolosi e malattia diverticolare |
IT201900016865A1 (it) * | 2019-09-20 | 2021-03-20 | Sofar Spa | Composizioni a base di ceppi batterici e loro uso come antinfiammatori |
US11751597B2 (en) | 2019-11-05 | 2023-09-12 | Alfasigma S.P.A. | Compositions comprising bacterial strains for use in increasing the bioavailability of amino acids derived from proteins, and related food product methods and systems |
CN118354780A (zh) * | 2021-11-12 | 2024-07-16 | 科赛生物技术有限公司 | 用于预防或治疗肌肉疾病的药物组合物 |
CN116606761B (zh) * | 2023-04-14 | 2024-03-12 | 微康益生菌(苏州)股份有限公司 | 一种能够缓解类风湿性关节炎的动物双歧杆菌乳亚种BLa19及其应用 |
CN117887643B (zh) * | 2024-03-14 | 2024-06-14 | 微康益生菌(苏州)股份有限公司 | 一种抗过敏的益生菌剂及其应用 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007269737A (ja) * | 2006-03-31 | 2007-10-18 | Morinaga Milk Ind Co Ltd | インターロイキン産生調節剤、該インターロイキン産生調節剤を含む医薬組成物及び飲食品、並びにその製造方法 |
JP5019961B2 (ja) * | 2006-06-26 | 2012-09-05 | 株式会社ヤクルト本社 | インターロイキン10産生促進剤 |
JP5238166B2 (ja) * | 2007-02-02 | 2013-07-17 | 株式会社ヤクルト本社 | インターロイキン12産生抑制剤 |
JP2009057346A (ja) * | 2007-09-03 | 2009-03-19 | Kirin Holdings Co Ltd | 免疫バランス調節用組成物 |
CA2754300C (en) * | 2009-03-05 | 2020-02-25 | Probiotical S.P.A. | Bacteria strains having a high anti-inflammatory activity |
JP5840368B2 (ja) * | 2011-02-02 | 2016-01-06 | カルピス株式会社 | 関節炎予防改善用物質 |
CN102919922A (zh) * | 2012-11-08 | 2013-02-13 | 黑龙江省轻工科学研究院 | 一种复合益生菌发酵蓝莓果汁粉的制备方法 |
ITMI20130793A1 (it) * | 2013-05-14 | 2014-11-15 | Probiotical Spa | Composizione comprendente batteri lattici per uso nel trattamento preventivo e/o curativo delle cistiti ricorrenti. |
TWI788111B (zh) * | 2015-01-02 | 2022-12-21 | 美商梅拉洛伊卡公司 | 多元補充品組成物 |
US20190076497A1 (en) * | 2017-09-11 | 2019-03-14 | Kenneth Davin Fine | Oral and intestinal health products |
KR20200096807A (ko) * | 2017-12-06 | 2020-08-13 | 락2바이오메 에스.알.엘. | 프로바이오틱스 조성물 및 그 용도 |
CN108004189B (zh) * | 2018-01-18 | 2021-07-27 | 北京科拓恒通生物技术股份有限公司 | 一种复合益生乳酸菌粉剂及其制备方法与应用 |
FI128916B (en) * | 2018-02-05 | 2021-03-15 | Vetcare Oy | Health-promoting composition and method for its preparation |
CN108743851A (zh) * | 2018-08-09 | 2018-11-06 | 深圳市博奥生物科技有限公司 | 一种复合益生菌粉的制备方法及复合益生菌粉 |
-
2019
- 2019-09-20 IT IT102019000016850A patent/IT201900016850A1/it unknown
-
2020
- 2020-09-21 AU AU2020347962A patent/AU2020347962A1/en active Pending
- 2020-09-21 BR BR112022004976A patent/BR112022004976A2/pt unknown
- 2020-09-21 CA CA3154980A patent/CA3154980A1/en active Pending
- 2020-09-21 CN CN202080065671.XA patent/CN114728033A/zh active Pending
- 2020-09-21 MX MX2022003375A patent/MX2022003375A/es unknown
- 2020-09-21 JP JP2022518387A patent/JP2023507048A/ja active Pending
- 2020-09-21 EP EP20792483.8A patent/EP4031156A2/en active Pending
- 2020-09-21 WO PCT/IB2020/058777 patent/WO2021053641A2/en active Application Filing
- 2020-09-21 US US17/761,920 patent/US20220370520A1/en active Pending
-
2022
- 2022-03-16 IL IL291448A patent/IL291448A/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO2021053641A2 (en) | 2021-03-25 |
JP2023507048A (ja) | 2023-02-21 |
US20220370520A1 (en) | 2022-11-24 |
CA3154980A1 (en) | 2021-03-25 |
AU2020347962A1 (en) | 2022-03-31 |
WO2021053641A3 (en) | 2021-05-20 |
IT201900016850A1 (it) | 2021-03-20 |
IL291448A (en) | 2022-05-01 |
MX2022003375A (es) | 2022-07-12 |
CN114728033A (zh) | 2022-07-08 |
EP4031156A2 (en) | 2022-07-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112022004527A2 (pt) | Composições com base em cepas bacterianas e seu uso como anti-inflamatórios | |
BR112022004976A2 (pt) | Composições com base em cepas bacterianas e extratos de baga e uso do mesmo como anti-inflamatórios | |
BR112022004569A2 (pt) | Cepas bacterianas, suas composições e seu uso para o tratamento de distúrbios gastrointestinais | |
BR112018077266A2 (pt) | composições compreendendo cepas bacterianas | |
CO2022006972A2 (es) | Composiciones que comprenden cepas bacterianas para uso en el aumento de la biodisponibilidad de aminoácidos derivados de proteínas | |
NZ777234A (en) | Compositions comprising bacterial strains | |
BRPI1014081A2 (pt) | uso de uma bactéria da espécie bifidobacterium animalis subsp lactis cepa 420 (b420) ou uma mistura da mesma | |
BR112018003123A2 (pt) | composição, enema, cepa isolada, método para tratamento e/ou prevenção de uma condição gastrointestinal, e, uso de uma composição, de um enema ou de uma ou mais de uma cepa bacteriana isolada | |
BR112019025381A2 (pt) | Uso de bactérias de ácido láctico para tratar ou prevenir pelo menos uma dentre depressão pós-natal e ansiedade pós-natal | |
BR112018074867A2 (pt) | composição nutricional compreendendo um probiótico para a prevenção e/ou tratamento de distúrbios de ansiedade e condições relacionadas em um mamífero | |
BR112018003753A2 (pt) | bifidobacterium longum | |
BR112019001116A2 (pt) | composição probiótica usada no tratamento e/ou prevenção da dermatite atópica | |
BR112012028893A2 (pt) | composições imunoestimuladoras e de vacina | |
BRPI0516230A (pt) | cepa natural de streptococcus thermophilus ami deficiente com pós-acidificação reduzida, e suas variantes naturais ami deficientes, processo de preparação de um produto alimenticio fermentado, produto alimenticio fermentado, e, utilização de pelo menos uma cepa | |
AR106385A1 (es) | Composición cosmética que comprende bacterias probióticas | |
BR112016000901B8 (pt) | composições, métodos para a preparação de um produto e produtos alimentícios ou para alimentação animal | |
BR112018070512A2 (pt) | composição, usos de uma composição e método para aumentar a massa corporal magra | |
MX2021009398A (es) | Composiciones probioticas que comprenden cepas de lactobacillus reuteri y metodos de uso. | |
AU2019263623A8 (en) | Probiotic Bifidobacterium breve strain and compositions comprising said strain | |
MX2022007999A (es) | Streptococcus thermophilus negativo a sacarosa para su uso en la preparación de productos fermentados. | |
WO2017199022A3 (en) | Lactobacillus rhamnosus lysate compositions and uses thereof | |
BR112018014654A2 (pt) | cepa inovadora de bactérias probióticas e composições e usos da mesma | |
CO2017007338A2 (es) | Composición que comprende dos cepas de las especies microbianas lactobacillus rhamnosus y bifidobacterium longum capaces de incrementar la fertilidad masculina | |
WO2015121458A3 (fr) | Utilisations de compositions comprenant du bifidobacterium animalis ssp. lactis lmg p-28149 | |
WO2012009774A3 (pt) | Microrganismos recombinantes, métodos de preparação de linhagens vacinais, antígenos, composições vacinais vetorizadas, seus usos, anticorpos, kit de diagnóstico e métodos de tratamento e/ou profilaxia |